« Previous
Next »
Titles
- Investigational in vitro diagnostics in oncology trials: streamlined submission process for study risk determination1
- Investigational new drugs: FDA has taken steps to improve the expanded access program but should further clarify how adverse events data are used : report to Congressional addressees1